Clinical Trials Logo

Arthritis, Infectious clinical trials

View clinical trials related to Arthritis, Infectious.

Filter by:

NCT ID: NCT05234385 Completed - Clinical trials for Sternoclavicular Joint Infection

Functional Outcome Following Surgical Treatment of Patients With Sternoclavicular Joint Infection

SCJ Infection
Start date: January 2, 2022
Phase:
Study type: Observational

The Sternoclavicular joints (SCJ) represents an important factor in stability of shoulder joint. Its influence and its function is important for the functionality of the shoulder. SCJ infection is a rare condition and remains often mistreated and potentially life threatening. This study is to assess the cases treated at the University Hospital Basel with a surgical approach of extended resection of the SCJ. One prospective follow-up visit inclusive one physical examination per patient will be performed to evaluate the long-term functional results of arm, shoulder, hand function with the QuickDASH questionnaire.

NCT ID: NCT05211011 Active, not recruiting - Clinical trials for Prosthetic Joint Infection

Efficacy and Safety of Intravenous Fosfomycin in Prosthetic Joint Infection

Start date: January 23, 2018
Phase: Phase 4
Study type: Interventional

The PROOF Study is an open prospective interventional non-randomized study which aim is to determine the outcome / effect and safety of fosfomycin in patients with hip, knee or shoulder PJI.

NCT ID: NCT05159739 Enrolling by invitation - Clinical trials for Total Joint Arthroplasty

Genetic Susceptibility to Periprosthetic Joint Infections

Start date: March 7, 2018
Phase:
Study type: Observational

The investigators primary objective is to identify genetic factors that may increase the risk of patients developing a periprosthetic joint infections (PJI) following total joint arthroplasty (TJA). The investigators hope that by identifying genetic predispositions we will be able to provide patient specific care pathways to prevent or minimize the risk for PJI.

NCT ID: NCT05137314 Recruiting - Joint Infection Clinical Trials

Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

Start date: March 31, 2022
Phase: Phase 1
Study type: Interventional

The purpose of this study is to learn about the safety and effects of PLG0206 for treating periprosthetic joint infections (PJI) in conjunction with the DAIR (debridement, antibiotics and implant retention) surgical procedure for patients with periprosthetic joint infections (PJI) after total knee arthroplasty (TKA) .

NCT ID: NCT05117671 Completed - Clinical trials for Periprosthetic Joint Infection (PJI)

Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?

Start date: April 16, 2021
Phase:
Study type: Observational

This retrospective multi-center, multi-national cohort study is to validate the European Bone and Joint Infection Society (EBJIS) Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).

NCT ID: NCT05060952 Recruiting - Clinical trials for Arthroplasty Complications

Calprotectin in Chronic Prosthetic Joint Infection

Start date: March 1, 2019
Phase:
Study type: Observational

A bacterial infection of an artificial joint is a serious complication that often requires additional surgery to exchange the arthroplasty. It is also difficult to recognize an infected joint, as the symptoms caused by the infection are very similar to those of other problems with arthroplasties, such as loosening of the implant. To improve the ability to diagnose prosthetic joint infections, this study compares the levels of calprotectin, a specific inflammatory protein, in the joint fluid of infected joints and joints with other complications. The underlying hypothesis is that the level of calprotectin in infected joints is significantly higher, thus facilitating the diagnosis of prosthetic joint infection.

NCT ID: NCT05000723 Recruiting - Clinical trials for Prosthetic Joint Infection

Long Term Follow-up of Patients With Prosthetic Joint Infection of the Hip Treated at University Hospitals Leuven

PROFITH
Start date: July 14, 2022
Phase:
Study type: Observational [Patient Registry]

Prosthetic Joint Infection (PJI) of a Total Hip Replacement (THR) is a disastrous complication of an otherwise extremely successful surgical procedure. It is associated with a burdensome treatment for the patient, significant challenges for the medical team and high costs for society. As more joint replacements are being performed each year, due to an ageing population and lower thresholds for surgery, the number of PJIs is on the rise. Many of these patients will be referred to University Hospitals Leuven as the physicians have extensive experience with this particular pathology and can offer a multidisciplinary and patient-tailored treatment. Many controversies exist in the field of PJI treatment, both with regard to the surgical aspects as well as the antibiotic treatment. Setting up randomized controlled trials to answer these questions has been proven to be very difficult due to large variations in patients, implants, germs, soft and hard tissues, antibiotic resistance patterns, and so on. Also, surgery for PJIs is usually non-elective / semi-urgent and therefore time to include patients into different trials is limited. Therefore the investigators will prospectively collect data on patients with PJI treated at University Hospitals Leuven, starting 01/01/2022, in order to have knowledge of own results and inform patients about chances of success prior to treatment; perform internal audits and quality checks; answer questions in the field of PJI treatment not suitable for RCTs.

NCT ID: NCT04952220 Recruiting - Knee Arthritis Clinical Trials

Exploratory Study of Ultrasound Signs of Native Septic Arthritis of the Knee

USAK
Start date: October 27, 2021
Phase:
Study type: Observational

Primary objective: Description of ultrasound abnormalities seen in native septic arthritis of the knee during each visit. Primary endpoint: Describe the ultrasound abnormalities observed on Day 0, Day 10, 6 weeks, 3 months, 6 months, during native septic arthritis of the knee.

NCT ID: NCT04948281 Completed - Joint Infection Clinical Trials

Joint Infection Following ACL Reconstruction

Start date: January 1, 2019
Phase:
Study type: Observational

This study was conducted to analyze the effect of joint infection on the bone tunnel, graft and articular cartilage following arthroscopic single-bundle anterior cruciate ligament (ACL) reconstruction with autologous hamstring, to summarize the features of MR findings after joint infection, and to correlate these findings with their possible factors.

NCT ID: NCT04946500 Active, not recruiting - Clinical trials for Prosthetic Joint Infection

Clindamycin in Prosthetic Joint Infections Caused by Staphylococcus (CISTA)

CISTA
Start date: May 15, 2021
Phase:
Study type: Observational

The alternatives to the combination of Fluoroquinolone and Rifampicin in prosthetic joint infections (PJI) caused by staphylococcus are currently unclear. Clindamycin is prescribed as dual therapy in this indication, and provides many advantages. We conducted a multicenter retrospective observational study evaluating the efficacy and safety of Clindamycin in prosthetic joint infections due to staphylococcus between January 2013 and December 2019.